BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38501385)

  • 1. The RNA-binding protein sorbin and SH3 domain-containing 2 are transcriptionally regulated by specificity protein 1 and function as tumor suppressors in bladder cancer by stabilizing tissue factor pathway inhibitor.
    Wang B; Fan X; Wang L; Wei X
    Mol Carcinog; 2024 Jun; 63(6):1174-1187. PubMed ID: 38501385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
    Han L; Huang C; Zhang S
    Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
    Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
    J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High LINC01605 expression predicts poor prognosis and promotes tumor progression via up-regulation of MMP9 in bladder cancer.
    Qin Z; Wang Y; Tang J; Zhang L; Li R; Xue J; Han P; Wang W; Qin C; Xing Q; Yang J; Zhang W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0001944 promotes the growth and metastasis in bladder cancer cells by acting as a competitive endogenous RNA for miR-548.
    Jin M; Lu S; Wu Y; Yang C; Shi C; Wang Y; Huang G
    J Exp Clin Cancer Res; 2020 Sep; 39(1):186. PubMed ID: 32928266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing circ‑BIRC6 inhibits the proliferation, invasion, migration and epithelial‑mesenchymal transition of bladder cancer cells by targeting the miR‑495‑3p/XBP1 signaling axis.
    Zhou L; Wang B; Zhang Y; Yao K; Liu B
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34542161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis.
    Liu H; Bi J; Dong W; Yang M; Shi J; Jiang N; Lin T; Huang J
    Mol Cancer; 2018 Nov; 17(1):161. PubMed ID: 30458784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circST6GALNAC6 suppresses bladder cancer metastasis by sponging miR-200a-3p to modulate the STMN1/EMT axis.
    Tan S; Kang Y; Li H; He HQ; Zheng L; Wu SQ; Ai K; Zhang L; Xu R; Zhang XZ; Zhao XK; Zhu X
    Cell Death Dis; 2021 Feb; 12(2):168. PubMed ID: 33568625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p.
    Yang C; Yang Y; Wang W; Zhou W; Zhang X; Xiao Y; Zhang H
    Cell Oncol (Dordr); 2022 Dec; 45(6):1217-1236. PubMed ID: 36374443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of lncRNA ZNRD1-AS1 inhibits progression of bladder cancer by regulating miR-194 and ZEB1.
    Gao Z; Li S; Zhou X; Li H; He S
    Cancer Med; 2020 Oct; 9(20):7695-7705. PubMed ID: 32862492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing circular RNA VANGL1 inhibits progression of bladder cancer by regulating miR-1184/IGFBP2 axis.
    Yang D; Qian H; Fang Z; Xu A; Zhao S; Liu B; Li D
    Cancer Med; 2020 Jan; 9(2):700-710. PubMed ID: 31758655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
    Yang J; Fan L; Liao X; Cui G; Hu H
    Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Filamin A (FLNA) regulates autophagy of bladder carcinoma cell and affects its proliferation, invasion and metastasis.
    Wang Z; Li C; Jiang M; Chen J; Yang M; Pu J
    Int Urol Nephrol; 2018 Feb; 50(2):263-273. PubMed ID: 29288417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA cTFRC acts as the sponge of MicroRNA-107 to promote bladder carcinoma progression.
    Su H; Tao T; Yang Z; Kang X; Zhang X; Kang D; Wu S; Li C
    Mol Cancer; 2019 Feb; 18(1):27. PubMed ID: 30782157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
    Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
    Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EIF5A2 predicts outcome in localised invasive bladder cancer and promotes bladder cancer cell aggressiveness in vitro and in vivo.
    Wei JH; Cao JZ; Zhang D; Liao B; Zhong WM; Lu J; Zhao HW; Zhang JX; Tong ZT; Fan S; Liang CZ; Liao YB; Pang J; Wu RH; Fang Y; Chen ZH; Li B; Xie D; Chen W; Luo JH
    Br J Cancer; 2014 Apr; 110(7):1767-77. PubMed ID: 24504366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte elevated gene-1 promotes invasion and epithelial-mesenchymal transition in bladder cancer cells through activation of signal transducer and activator of transcription 3.
    Yang X; Shi L; Yi C; Yang Y; Chang L; Song D
    Int J Urol; 2018 Feb; 25(2):157-163. PubMed ID: 29117631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTTG1 regulated by miR-146a-3p promotes bladder cancer migration, invasion, metastasis and growth.
    Xiang W; Wu X; Huang C; Wang M; Zhao X; Luo G; Li Y; Jiang G; Xiao X; Zeng F
    Oncotarget; 2017 Jan; 8(1):664-678. PubMed ID: 27893422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR‑145‑5p/TOP2A axis.
    Du Y; Zhang X; Zhang H; Chen Y; Zhu S; Shu J; Pan H
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RNA binding protein SORBS2 suppresses metastatic colonization of ovarian cancer by stabilizing tumor-suppressive immunomodulatory transcripts.
    Zhao L; Wang W; Huang S; Yang Z; Xu L; Yang Q; Zhou X; Wang J; Shen Q; Wang C; Le X; Feng M; Zhou N; Lau WB; Lau B; Yao S; Yi T; Wang X; Zhao X; Wei Y; Zhou S
    Genome Biol; 2018 Mar; 19(1):35. PubMed ID: 29548303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.